On September 25, 2019, Sirio Health technology co., LTD. (stock code: 300791) officially listed on the A-share market in Shenzhen, starting a new journey leading health technology. The stock price of Sirio Health rose by the daily limit to 76.60 yuan on the first day of trading, up 39.96%.
Founded in 1993, Sirio Health, witnessed more than 25 years of participation in China's nutritional health care industry, has always focused on the development and production of nutritional health food. Consumer demand-oriented, and constantly develop a variety of dosage-based technology product applications, for customers at home and abroad to provide one-stop product solutions.
Mr. Lin peiqing, President of Sirio Health, introduced that Sirio Health has accelerated the pace of development in the past 10 years. While based in China, we have added marketing centers in America and Europe and acquired European factories. Now we have 3 R&D centers in Germany and 4 modern production bases.
Nowadays, Sirio Health has grown into a globally influential integrated provider of nutritional health food services. After the successful listing, I firmly believe that Sirio Health will focus on the integration of more market advantages resources, assume more social responsibility, to build a world-class health technology brand from China.
- 2020 Asiaceutical Summit & Expo Agenda
- Herbridge Online Meeting：Natural health products industry——Global trends in the first half of 2020
- Four Food Ingredients were approved in China 2020
- Yili QQ star formula milk initial on the market
- Chinese people's intestinal Health 2020 report released
- Panpan foods is entering into sports drinks
- Mengniu high-end immunity milk powder brand new Tekangli listed
- Danone introduces plant-based supplements to China for the first time
- Swisse China President: Consumers are aware of the importance of immunity
- China Resources Pharm’s new gastrointestinal product “Jiangzhong Lihuo Probiotics” was officially launched